keyword
https://read.qxmd.com/read/38657119/single-cell-analysis-revealing-the-metabolic-landscape-of-prostate-cancer
#1
JOURNAL ARTICLE
Jing Wang, He-Kang Ding, Han-Jiang Xu, De-Kai Hu, William Hankey, Li Chen, Jun Xiao, Chao-Zhao Liang, Bing Zhao, Ling-Fan Xu
Tumor metabolic reprogramming is a hallmark of cancer development, and targeting metabolic vulnerabilities has been proven to be an effective approach for castration-resistant prostate cancer (CRPC) treatment. Nevertheless, treatment failure inevitably occurs, largely due to cellular heterogeneity, which cannot be deciphered by traditional bulk sequencing techniques. By employing computational pipelines for single-cell RNA sequencing, we demonstrated that epithelial cells within the prostate are more metabolically active and plastic than stromal cells...
April 23, 2024: Asian Journal of Andrology
https://read.qxmd.com/read/38656317/establishment-of-human-pituitary-neuroendocrine-tumor-derived-organoid-and-its-pilot-application-for-drug-screening
#2
JOURNAL ARTICLE
Run Cui, Hao Duan, Wanming Hu, Chang Li, Sheng Zhong, Lun Liang, Siyu Chen, Hongrong Hu, Zhenqiang He, Zhenning Wang, Xiaoyu Guo, Zexin Chen, Cong Xu, Yu Zhu, Yinsheng Chen, Ke Sai, Qunying Yang, Chengcheng Guo, Yonggao Mou, Xiaobing Jiang
CONTEXT: Precision medicine for pituitary neuroendocrine tumors (PitNETs) is limited by the lack of reliable research models. OBJECTIVE: To generate patient-derived organoids (PDOs), which could serve as a platform for personalized drug screening for PitNET patients. DESIGN: From July 2019 to May 2022, a total of 32 human PitNET specimens were collected for the establishment of organoids with an optimized culture protocol. SETTING: This study was conducted at Sun Yat-Sen University Cancer Center...
April 24, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38656092/how-to-standardize-the-diagnostic-approach-to-pituitary-neuroendocrine-tumors
#3
JOURNAL ARTICLE
Sofia Asioli, Federica Guaraldi, Matteo Zoli, Diego Mazzatenta, Chiara Villa
Pituitary tumors present heterogeneous biochemical, clinico-radiological, and histological features. Although histologically benign, a non-negligible number of cases present an unpredictable aggressive behavior with local invasiveness, partial/complete resistance to treatment and/or recurrence after surgery, and, rarely, metastasize, overall leading to a significant increase of morbidity, and, thus, requiring skilled multidisciplinary management in referral Centers. Histopathological diagnosis is essential to stratify cancer patient risk and uniform follow-up among Centers...
April 24, 2024: Minerva endocrinology
https://read.qxmd.com/read/38655905/short-term-biological-toxicity-prediction-of-177-lu-lutetium-oxodotreotide-an-original-retrospective-analysis
#4
JOURNAL ARTICLE
Julien Dubois, Guillaume Tosato, Philippe Garrigue, David Taieb, Benjamin Guillet, Vincent Nail
Introduction: [177 Lu]Lutetium (Lu)-oxodotreotide is a radiopharmaceutical drug used as peptide receptor radionuclide therapy (PRRT) for somatostatin receptor-expressing neuroendocrine neoplasms. It provides an additional effective alternative treatment for these rare cancers. Although well tolerated, its safety profile must continue to be characterized to support its use as a first-line treatment or for additional cycles. This study aims to evaluate factors associated with the occurrence of [177 Lu]Lu-oxodotreotide induced short-term toxicity...
April 24, 2024: Cancer Biotherapy & Radiopharmaceuticals
https://read.qxmd.com/read/38655135/gastric-mixed-neuroendocrine-non-neuroendocrine-neoplasms
#5
REVIEW
Li Liu, Qian Li, Wenxuan Liu, Zhendong Qiu, Zhongkai Wu, Danli Yu, Wenhong Deng
The uncommon tumour known as gastric mixed neuroendocrine-non-neuroendocrine neoplasms (G-MiNENs) is made up of parts of neuroendocrine carcinoma and adenocarcinoma. The biological and clinical features are different from those of gastric adenocarcinoma. Their pathophysiology, diagnostic standards, and clinical behaviour have all been the subject of lengthy debates, and their nomenclature has undergone multiple changes. Its emergence has created new challenges in the classification and diagnosis of gastric tumours...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38654072/zeb1-controlled-metabolic-plasticity-enables-remodeling-of-chromatin-accessibility-in-the-development-of-neuroendocrine-prostate-cancer
#6
JOURNAL ARTICLE
Deng Wang, Genyu Du, Xinyu Chen, Jinming Wang, Kaiyuan Liu, Huifang Zhao, Chaping Cheng, Yuman He, Na Jing, Penghui Xu, Wei Bao, Xialian Xi, Yingchao Zhang, Nan Wang, Yiyun Liu, Yujiao Sun, Kai Zhang, Pengcheng Zhang, Wei-Qiang Gao, Helen He Zhu
Cell plasticity has been found to play a critical role in tumor progression and therapy resistance. However, our understanding of the characteristics and markers of plastic cellular states during cancer cell lineage transition remains limited. In this study, multi-omics analyses show that prostate cancer cells undergo an intermediate state marked by Zeb1 expression with epithelial-mesenchymal transition (EMT), stemness, and neuroendocrine features during the development of neuroendocrine prostate cancer (NEPC)...
April 23, 2024: Cell Death and Differentiation
https://read.qxmd.com/read/38652200/radio-guided-surgery-with-a-new-generation-%C3%AE-probe-for-radiolabeled-somatostatin-analog-in-patients-with-small-intestinal-neuroendocrine-tumors
#7
JOURNAL ARTICLE
Emilio Bertani, Francesco Mattana, Francesco Collamati, Mahila E Ferrari, Vincenzo Bagnardi, Samuele Frassoni, Eleonora Pisa, Riccardo Mirabelli, Silvio Morganti, Nicola Fazio, Uberto Fumagalli Romario, Francesco Ceci
BACKGROUND: Radio-guided surgery (RGS) holds promise for improving surgical outcomes in neuroendocrine tumors (NETs). Previous studies showed low specificity (SP) using γ-probes to detect radiation emitted by radio-labeled somatostatin analogs. OBJECTIVE: We aimed to assess the sensitivity (SE) and SP of the intraoperative RGS approach using a β-probe with a per-lesion analysis, while assessing safety and feasibility as secondary objectives. METHODS: This prospective, single-arm, single-center, phase II trial (NCT05448157) enrolled 20 patients diagnosed with small intestine NETs (SI-NETs) with positive lesions detected at 68 Ga-DOTA-TOC positron emission tomography/computed tomography (PET/CT)...
April 23, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38651961/-cancer-associated-cachexia-an-unresolved-disease
#8
JOURNAL ARTICLE
Jean Bastin
Cachexia is a systemic wasting condition associated to advanced phases of many cancers, which contributes to significant morbidity and mortality. It is mainly characterized by involuntary weight loss due to muscle wasting often associated with loss of adipose tissue, possibly leading to inanition and death, without treatment to date. Symptomatology covers a complex array of disorders (fatigue, inflammation, pain, anorexia, depression) related to multisystemic impairments progressively affecting numerous organs and tissues (muscle, adipose tissue, brain, immune system, gastrointestinal tract)...
April 2024: Médecine Sciences: M/S
https://read.qxmd.com/read/38651600/occult-appendix-pathology-in-patients-undergoing-colorectal-cancer-resection-and-prophylactic-appendectomy
#9
JOURNAL ARTICLE
Francesco Di Fabio, Prabhu Ravi, Niccolo Allievi, Kashuf A Khan, Abu Abduelraheim, Brendan Moran
BACKGROUND: The risk-benefit balance of prophylactic appendectomy in patients undergoing left colorectal cancer resection is unclear. The aim of this report is to assess the proportion of histologically abnormal appendices in patients undergoing colorectal cancer resection in a unit where standard of care is appendectomy, with consent, when left-sided resection is performed. METHODS: A retrospective study on a prospectively collected database was conducted in a single tertiary-care center...
January 2024: World Journal of Surgery
https://read.qxmd.com/read/38649621/merkel-cell-carcinoma-integrating-epidemiology-immunology-and-therapeutic-updates
#10
REVIEW
Jürgen C Becker, Andreas Stang, David Schrama, Selma Ugurel
Merkel cell carcinoma (MCC) is a rare skin cancer characterized by neuroendocrine differentiation. Its carcinogenesis is based either on the integration of the Merkel cell polyomavirus or on ultraviolet (UV) mutagenesis, both of which lead to high immunogenicity either through the expression of viral proteins or neoantigens. Despite this immunogenicity resulting from viral or UV-associated carcinogenesis, it exhibits highly aggressive behavior. However, owing to the rarity of MCC and the lack of epidemiologic registries with detailed clinical data, there is some uncertainty regarding the spontaneous course of the disease...
April 22, 2024: American Journal of Clinical Dermatology
https://read.qxmd.com/read/38645232/pgc-1%C3%AE-drives-small-cell-neuroendocrine-cancer-progression-towards-an-ascl1-expressing-subtype-with-increased-mitochondrial-capacity
#11
Grigor Varuzhanyan, Chia-Chun Chen, Jack Freeland, Tian He, Wendy Tran, Kai Song, Liang Wang, Donghui Cheng, Shili Xu, Gabriella A Dibernardo, Favour N Esedebe, Evan R Abt, Jung Wook Park, Sanaz Memarzadeh, Thomas Graeber, Orian Shirihai, Owen Witte
Adenocarcinomas from multiple tissues can converge to treatment-resistant small cell neuroendocrine (SCN) cancers comprised of ASCL1, POU2F3, NEUROD1, and YAP1 subtypes. We investigated how mitochondrial metabolism influences SCN cancer (SCNC) progression. Extensive bioinformatics analyses encompassing thousands of patient tumors and human cancer cell lines uncovered enhanced expression of PGC-1α, a potent regulator of mitochondrial oxidative phosphorylation (OXPHOS), across several SCNC types. PGC-1α correlated tightly with increased expression of the lineage marker ASCL1 through a positive feedback mechanism...
April 13, 2024: bioRxiv
https://read.qxmd.com/read/38645223/the-neuroendocrine-transition-in-prostate-cancer-is-dynamic-and-dependent-on-ascl1
#12
Rodrigo Romero, Tinyi Chu, Tania J González-Robles, Perianne Smith, Yubin Xie, Harmanpreet Kaur, Sara Yoder, Huiyong Zhao, Chenyi Mao, Wenfei Kang, Maria V Pulina, Kayla E Lawrence, Anuradha Gopalan, Samir Zaidi, Kwangmin Yoo, Jungmin Choi, Ning Fan, Olivia Gerstner, Wouter R Karthaus, Elisa DeStanchina, Kelly V Ruggles, Peter M K Westcott, Ronan Chaligné, Dana Pe'er, Charles L Sawyers
Lineage plasticity is a recognized hallmark of cancer progression that can shape therapy outcomes. The underlying cellular and molecular mechanisms mediating lineage plasticity remain poorly understood. Here, we describe a versatile in vivo platform to identify and interrogate the molecular determinants of neuroendocrine lineage transformation at different stages of prostate cancer progression. Adenocarcinomas reliably develop following orthotopic transplantation of primary mouse prostate organoids acutely engineered with human-relevant driver alterations (e...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38645034/single-cell-analysis-of-treatment-resistant-prostate-cancer-implications-of-cell-state-changes-for-cell-surface-antigen-targeted-therapies
#13
Samir Zaidi, Jooyoung Park, Joseph M Chan, Martine P Roudier, Jimmy L Zhao, Anuradha Gopalan, Kristine M Wadosky, Radhika A Patel, Erolcan Sayar, Wouter R Karthaus, D Henry Kates, Ojasvi Chaudhary, Tianhao Xu, Ignas Masilionis, Linas Mazutis, Ronan Chaligné, Aleksandar Obradovic, Irina Linkov, Afsar Barlas, Achim Jungbluth, Natasha Rekhtman, Joachim Silber, Katia Manova-Todorova, Philip A Watson, Lawrence D True, Colm M Morrissey, Howard I Scher, Dana Rathkopf, Michael J Morris, David W Goodrich, Jungmin Choi, Peter S Nelson, Michael C Haffner, Charles L Sawyers
UNLABELLED: Targeting cell surface molecules using radioligand and antibody-based therapies has yielded considerable success across cancers. However, it remains unclear how the expression of putative lineage markers, particularly cell surface molecules, varies in the process of lineage plasticity, wherein tumor cells alter their identity and acquire new oncogenic properties. A notable example of lineage plasticity is the transformation of prostate adenocarcinoma (PRAD) to neuroendocrine prostate cancer (NEPC)--a growing resistance mechanism that results in the loss of responsiveness to androgen blockade and portends dismal patient survival...
April 12, 2024: bioRxiv
https://read.qxmd.com/read/38644268/-therapeutic-efficacy-analysis-of-endoscopic-combined-with-serological-diagnosis-strategy-and-endoscopic-in-g1-and-g2-gastric-neuroendocrine-neoplasms
#14
JOURNAL ARTICLE
W Y Li, Y Liu, Y M Zhang, L Z Dou, S He, Y Ke, X D Liu, Y M Liu, H R Wu, G Q Wang
Objective: To investigate the endoscopic combined serological diagnosis strategy for G1 and G2 gastric neuroendocrine neoplasms (G-NENs), and to evaluate the safety, short-term, and long-term efficacy of two endoscopic treatment procedures: endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD). Methods: This study retrospectively analyzed the clinical data of 100 consecutive patients with G-NENs who were hospitalized at the Cancer Hospital of the Chinese Academy of Medical Sciences from January 2011 to October 2023...
April 23, 2024: Zhonghua Zhong Liu za Zhi [Chinese Journal of Oncology]
https://read.qxmd.com/read/38643954/psychoneuroimmunology-in-multiple-myeloma-and-autologous-hematopoietic-stem-cell-transplant-opportunities-for-research-among-patients-and-caregivers
#15
REVIEW
Lisa M Christian, Janice K Kiecolt-Glaser, Steve W Cole, Christin E Burd, Annelise A Madison, Stephanie J Wilson, Ashley E Rosko
Multiple myeloma (MM) is an incurable cancer and is the leading indication for autologous hematopoietic stem cell transplantation (HSCT). To be eligible for HSCT, a patient must have a caregiver, as caregivers play a central role in HSCT preparation and recovery. MM patients remain on treatment indefinitely, and thus patients and their caregivers face long-term challenges including the intensity of HSCT and perpetual therapy after transplant. Importantly, both patients and their caregivers show heightened depressive and anxiety symptoms, with dyadic correspondence evidenced and caregivers' distress often exceeding that of patients...
April 19, 2024: Brain, Behavior, and Immunity
https://read.qxmd.com/read/38642579/neuropilin-2-and-soluble-neuropilin-2-in-neuroendocrine-neoplasms
#16
JOURNAL ARTICLE
Laura Gerard, Céline Patte, Laurence Chardon, Valerie Hervieu, Léa Payen, Marion Allio, Claire Marx, Hugo Clermidy, Alice Durand, Patrick Mehlen, Julien Bollard, Gilles Poncet, Colette Roche, Benjamin Gibert, Thomas Walter
Neuropilin-2 (NRP2), a transmembrane non-tyrosine kinase receptor, has been described as a potential critical player in the tumourigenesis of several solid cancers, and particularly in neuroendocrine neoplasms (NEN). A soluble form of NRP2 (sNRP2) has been previously described and corresponds to a truncated splice isoform. Its prognostic value has never been studied in NEN. NRP2 expression was studied by immunochemistry on tissue microarrays (n=437) and on circulating tumour cells (CTC, n=5 patients with neuroendocrine carcinoma, NEC)...
April 1, 2024: Endocrine-related Cancer
https://read.qxmd.com/read/38639572/belzutifan-a-novel-therapeutic-for-the-management-of-von-hippel-lindau-disease-and-beyond
#17
REVIEW
Lauren Curry, Maryam Soleimani
The identification of the VHL gene and its role in regulating the hypoxia-inducible factor signaling pathway has helped to revolutionize the treatment of renal cell carcinoma (RCC). Belzutifan is a novel small-molecule inhibitor of hypoxia-inducible factor 2α which has demonstrated efficacy in treating von Hippel-Lindau (VHL) disease, earning regulatory approvals for this indication. There is also early evidence for efficacy in sporadic RCC. Belzutifan has a favorable safety profile. Several clinical trials are currently ongoing, which should help in identifying this promising drug's role in RCC and beyond...
April 19, 2024: Future Oncology
https://read.qxmd.com/read/38635931/prognostic-model-for-high-grade-neuroendocrine-carcinoma-of-the-lung-incorporating-genomic-profiling-and-poly-adp-ribose-polymerase-1-expression
#18
JOURNAL ARTICLE
Hye Sook Kim, Jong Kwang Kim, Jeong Hyeon Lee, Young Joo Lee, Geon-Kuk Lee, Ji-Youn Han
PURPOSE: High-grade neuroendocrine carcinoma (HGNEC) of the lung is an aggressive cancer with a complex biology. We aimed to explore the prognostic value of genetic aberrations and poly(ADP-ribose) polymerase-1 (PARP1) expression in HGNEC and to establish a novel prognostic model. MATERIALS AND METHODS: We retrospectively enrolled 191 patients with histologically confirmed HGNEC of the lung. Tumor tissues were analyzed using PARP1 immunohistochemistry (IHC; N = 191) and comprehensive cancer panel sequencing (n = 102)...
April 2024: JCO Precision Oncology
https://read.qxmd.com/read/38634529/paraneoplastic-calmodulin-kinase-like-vesicle-associated-protein-camkv-autoimmune-encephalitis
#19
JOURNAL ARTICLE
Michael Gilligan, Connie E Lesnick, Yong Guo, Michael J Bradshaw, Shafeeq S Ladha, Mihaela Nowak, Maulik P Shah, John R Wittenborn, Eati Basal, Shannon Hinson, Binxia Yang, Divyanshu Dubey, John R Mills, Sean J Pittock, Anastasia Zekeridou, Andrew McKeon
OBJECTIVES: To report an autoimmune paraneoplastic encephalitis characterized by immunoglobulin G (IgG) antibody targeting synaptic protein calmodulin kinase-like vesicle-associated (CAMKV). METHODS: Serum and cerebrospinal fluid (CSF) samples harboring unclassified antibodies on murine brain-based indirect immunofluorescence assay (IFA) were screened by human protein microarray. In 5 patients with identical cerebral IFA staining, CAMKV was identified as top-ranking candidate antigen...
April 18, 2024: Annals of Neurology
https://read.qxmd.com/read/38633930/sunscreen-safety-and-efficacy-for-the-prevention-of-cutaneous-neoplasm
#20
REVIEW
Jonathan R Raymond-Lezman, Suzanne I Riskin
Sunscreen is widely used for ultraviolet radiation protection. Studies validate sun protection factors (SPFs) to prevent ultraviolet (UV)-induced skin changes such as melanoma and squamous cell carcinoma (SCC). Few studies examine sunscreen's impact on endocrine and immune system dysregulation, the production of radical oxygen species, and whether the ingredients deteriorate under prolonged exposure. We present an investigation of sunscreen labels and how ingredients impact sun safety and human health. A review of the literature was conducted using Embase and PubMed to examine sunscreen safety, efficacy, and use to prevent UV-induced skin damage...
March 2024: Curēus
keyword
keyword
44160
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.